Strategic Assessment of the Mitral and Aortic Valve: A Surgeon's Perpsective
This activity has been archived and credit is no longer available.
Dr. Moon will explore the various pathoanatomic changes that occur in the mitral and aortic valve apparatus that can lead to regurgitation. Analysis of pathoanatomic alterations will then be used to determine the most efficient mechanistic approach to repair rather than replace regurgitant valves. This recording has been made available from the Texas Heart Institute's Cardiology Grand Rounds series. CME credit is awarded from Texas Heart Institute.
Activity Information
This activity has been archived and credit is no longer available.
Needs Statement
Texas Heart Institute Cardiology Grand Rounds provides a weekly opportunity to learn from leading medical and surgical experts, sharing the latest advancements and innovations in the diagnosis, treatment, and prevention of cardiovascular disease. THI offers complimentary CME credits for participation in Grand Rounds On-Demand.
Educational Objectives
The intended result of this activity is increased knowledge. At the conclusion of this symposium, participants should be able to:
- Categorize three types of mitral valve pathology using the Carpentier classification.
- Differentiate mode of aortic regurgitation caused by changes in the valve leaflets versus changes in the functional aortic annulus.
- Describe techniques to repair the mitral and aortic valves .
Target Audience
Professional Categories
- Physicians
- Fellows
- Residents
- Nurses
- Other Health Professionals
Specialties
- Cardiology
Interest Groups
- Hospital Medicine
Accreditation/Credit Designation
Texas Heart Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Texas Heart Institute designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Acknowledgement of Support
This continuing medical education activity has been supported in part by educational grants from the following company: Edward Lifesciences, LLC.
Activity Director
-
Stephanie Coulter, M.D., FACC, FASE
Clinical Instructor
Texas Heart Institute, Baylor College of Medicine
Term of Approval
May 2, 2022 through May 2, 2024.
Disclosure Policy
Baylor College of Medicine (BCM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. BCM is committed to sponsoring CE activities that are scientifically based, accurate, current, and objectively presented.
In accordance with the ACCME Standards for Commercial Support, BCM has implemented a mechanism requiring everyone in a position to control the content of an educational activity (i.e., directors, planning committee members, faculty) to disclose any relevant financial relationships with commercial interests (drug/device companies) and manage/resolve any conflicts of interest prior to the activity. Individuals must disclose to participants the existence or non-existence of financial relationships at the time of the activity or within 24 months prior.
In addition, BCM has requested activity faculty/presenters to disclose to participants any unlabeled use or investigational use of pharmaceutical/device products; to use scientific or generic names (not trade names) in referring to products; and, if necessary to use a trade name, to use the names of similar products or those within a class. Faculty/presenters have also been requested to adhere to the ACCME's validation of clinical content statements.
BCM does not view the existence of financial relationships with commercial interests as implying bias or decreasing the value of a presentation. It is up to participants to determine whether the relationships influence the activity faculty with regard to exposition or conclusions. If at any time during this activity you feel that there has been commercial/promotional bias, notify the Activity Director or Activity Coordinator. Please answer the questions about balance and objectivity in the activity evaluation candidly.
All of the relevant financial relationships listed for these individuals have been mitigated.
Disclosures
The following individual(s) has/have reported financial or other relationship(s) with commercial entities whose products/services may relate to the educational content of this activity:
Presenter
-
Marc Moon, M.D.
Professor and Chief of the Division of Cardiothoracic Surgery
Baylor College of Medicine, Texas Heart Institute
Disclosure:
- Advisory Committee Membership: Medtronic
Activity Director
-
Stephanie Coulter, M.D., FACC, FASE
Clinical Instructor
Texas Heart Institute, Baylor College of Medicine
Disclosure:
Nothing to disclose.
Health Topics
Presenter: